|
|
Other links at Articles > Diabetes and Endocrinology |
| 5. |
Bivalirudin Reduces PCI Bleeding in Diabetics
|
|
|
Bivalirudin monotherapy is less likely than heparin to cause bleeding in diabetics undergoing percutaneous coronary intervention (PCI), Italian researchers report in the November 1 issue of the American Journal of Cardiology. Reuters Health Information
|
|
|